Fevertree Drinks PLC (AIM:FEVR)
London · Delayed Price · Currency is GBP · Price in GBX | Market Cap | 928.58M +0.3% |
| Revenue (ttm) | 325.00M -11.8% |
| Net Income | 22.60M -7.4% |
| EPS | 0.19 -10.7% |
| Shares Out | 112.55M |
| PE Ratio | 44.31 |
| Forward PE | 28.92 |
| Dividend | 0.17 (2.09%) |
| Ex-Dividend Date | May 21, 2026 |
| Volume | 406,346 |
| Open | 815.50 |
| Previous Close | 815.00 |
| Day's Range | 815.50 - 831.50 |
| 52-Week Range | 711.00 - 973.00 |
| Beta | 1.13 |
| Analysts | Hold |
| Price Target | 948.87 (+15.02%) |
| Earnings Date | Sep 10, 2026 |
About Fevertree Drinks
Fevertree Drinks PLC, together with its subsidiaries, engages in the development and sale of mixer drinks in the United Kingdom, the United States, Europe, and internationally. The company offers tonics, soft drinks, non-alcoholic, sodas, gingers, ready to drink, cocktail mixers, and cola and lemonades. It sells its products under the Fever-Tree brand name. The company was formerly known as Fevertree Topco Limited and changed its name to Fevertree Drinks PLC in October 2014. Fevertree Drinks PLC was founded in 2003 and is headquartered in Londo... [Read more]
Financial Performance
In 2025, Fevertree Drinks's revenue was 325.00 million, a decrease of -11.80% compared to the previous year's 368.50 million. Earnings were 22.60 million, a decrease of -7.38%.
Financial StatementsAnalyst Summary
According to 15 analysts, the average rating for FEVR stock is "Hold." The 12-month stock price target is 949p, which is an increase of 15.02% from the latest price.
News
Fevertree Drinks price target lowered to 780 GBp from 920 GBp at Berenberg
Berenberg lowered the firm’s price target on Fevertree Drinks (FQVTF) to 780 GBp from 920 GBp and keeps a Hold rating on the shares.
Fevertree Drinks price target raised to 900 GBp from 840 GBp at Deutsche Bank
Deutsche Bank raised the firm’s price target on Fevertree Drinks (FQVTF) to 900 GBp from 840 GBp and keeps a Hold rating on the shares.
Fevertree Drinks Earnings Call Transcript: H2 2025
Revenue grew 4% in 2025, driven by U.S. expansion and product diversification, with strong cash generation and improved margins. The Molson Coors partnership and robust supply chain position support confidence in 2026 EBITDA growth despite ongoing geopolitical risks.
Fevertree Drinks Annual report: H2 2025
Fevertree Drinks has published its H2 2025 annual report on March 24, 2026.
Fevertree Drinks Slides: H2 2025
Fevertree Drinks has posted slides in relation to its H2 2025 quarterly earnings report, which was published on March 24, 2026.
Fevertree Drinks Annual report: H2 2025
Fevertree Drinks has published its H2 2025 annual report on March 24, 2026.
Fevertree Drinks price target raised to 1,030 GBp from 900 GBp at RBC Capital
RBC Capital analyst Emma Letheren raised the firm’s price target on Fevertree Drinks (FQVTF) to 1,030 GBp from 900 GBp and keeps a Sector Perform rating on the shares. Published…
Fevertree Drinks upgraded to Overweight from Equal Weight at Barclays
Barclays upgraded Fevertree Drinks (FQVTF) to Overweight from Equal Weight with an unchanged price target of 1,270 GBp. The firm has increased confidence in the company’s Molson Coors partnership and…
Fevertree Drinks downgraded to Sell from Hold at Peel Hunt
Peel Hunt downgraded Fevertree Drinks (FQVTF) to Sell from Hold.
Fevertree Drinks Earnings release: Trading update
Fevertree Drinks released its earnings on January 29, 2026, summarizing the period's financial results.
Fevertree Drinks price target lowered to 850 GBp from 900 GBp at Citi
Citi lowered the firm’s price target on Fevertree Drinks (FQVTF) to 850 GBp from 900 GBp and keeps a Neutral rating on the shares.
Fevertree Drinks initiated with a Hold at Kepler Cheuvreux
Kepler Cheuvreux initiated coverage of Fevertree Drinks (FQVTF) with a Hold rating and 825 GBp price target The firm views the shares as fairly valued.
Fevertree Drinks upgraded to Buy from Hold at Jefferies
Jefferies analyst Edward Mundy upgraded Fevertree Drinks (FQVTF) to Buy from Hold with a price target of 1,100 GBp, up from 900 GBp. The firm says the company’s deal with…
Fevertree Drinks Earnings Call Transcript: H1 2025
H1 FY25 saw robust financials, with 2% constant currency growth and strong U.S. momentum from the Molson Coors partnership. Product diversification, especially ginger beer, is driving growth, while the expanded share buyback reflects confidence in future cash flows.
Fevertree Drinks Quarterly report: H1 2025
Fevertree Drinks has published its H1 2025 quarterly earnings report on September 11, 2025.
Fevertree Drinks Slides: H1 2025
Fevertree Drinks has posted slides in relation to its H1 2025 quarterly earnings report, which was published on September 11, 2025.
Fevertree Drinks downgraded to Underperform from Neutral at BNP Paribas Exane
BNP Paribas Exane downgraded Fevertree Drinks (FQVTF) to Underperform from Neutral with a 740 GBp price target The firm views the share rally year-to-date as overdone.
Fevertree Drinks price target raised to 790 GBp from 765 GBp at Morgan Stanley
Morgan Stanley raised the firm’s price target on Fevertree Drinks (FQVTF) to 790 GBp from 765 GBp and keeps an Equal Weight rating on the shares.
Fevertree Drinks price target raised to 900 GBp from 715 GBp at Citi
Citi raised the firm’s price target on Fevertree Drinks (FQVTF) to 900 GBp from 715 GBp and keeps a Neutral rating on the shares.
Fevertree and Molson Coors to split cost of US tariffs
Tonic maker Fevertree Drinks said on Thursday it would equally split costs of the 10% tariff to be imposed on the UK imports to the U.S. with brewer Molson Coors , as part of their recent tie-up to mi...
Fevertree Drinks Earnings release: Trading Update
Fevertree Drinks released its earnings on June 5, 2025, summarizing the period's financial results.
Fevertree Drinks price target lowered to 790 GBp from 860 GBp at Berenberg
Berenberg lowered the firm’s price target on Fevertree Drinks (FQVTF) to 790 GBp from 860 GBp and keeps a Hold rating on the shares.
Fevertree Drinks Earnings Call Transcript: H2 2024
Revenue grew 4% at constant currency with a 66% rise in Adjusted EBITDA and strong cash flow. The Molson Coors partnership in the U.S. is set to drive future growth, with guaranteed profits and reduced working capital needs, supporting expanded shareholder returns.
Fevertree Drinks Annual report: H2 2024
Fevertree Drinks has published its H2 2024 annual report on March 25, 2025.
Fevertree Drinks Annual report: H2 2024
Fevertree Drinks has published its H2 2024 annual report on March 25, 2025.